As the investment division of Viva Biotech Holdings (1873.HK), Viva BioInnovator (VBI) is dedicated to the identification and success of early-stage biotech start-ups through our incubation, equity-for-service, and investment platforms. We are committed to operating a collaborative platform for innovative biotech companies and anyone developing an idea with transformative potential. By leveraging our rich industry experience and technical advantages, VBI can provide R&D, working sites, logistic support, industrial docking, investment, and more to accelerate the transformation and commercialization of new drug discovery around the world. Visit vivabioinnovator.com for more information.
We Provide the 5 Key Ingredients to Start and Grow a Biotech Company
+ Strong Team
We insist the founders have strong integrity and a track record of company building and new drug R&D.
+ Groundbreaking Innovation
The “idea” needs to be innovative.
+ Patient Impact
There must be a true unmet medical need.
+ Market Demand
There must be significant market potential 5-10 years in the future.
Primarily innovative/novel therapeutics
Seed round to A-round stages, average investment amount between $0.5 million - $5 million
+ Investment Type
Cash, EFS, or a combination of EFS & Cash